Long-term efficacy of dupilumab in patients with moderate-to-severe type 2 inflammation by age of asthma onset: LIBERTY ASTHMA TRAVERSE study

被引：0
|
作者：
Busse, William W. [1 ]
Kraft, Monica [2 ]
Domingo, Christian [3 ]
de Mir, Ines [4 ]
Maselli, Diego [5 ]
Xia, Changming [6 ]
Pandit-Abid, Nami [7 ]
Soler, Xavier [8 ]
Jacob-Nara, Juby A. [9 ]
Sacks, Harry [10 ]
Rowe, Paul J. [11 ]
Deniz, Yamo [12 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, UW Allergy Pulm & Crit Care Med, Madison, WI 53706 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Univ Autonoma Barcelona, Pulm Serv, Barcelona, Spain
[4] Hosp Valle De Hebron, Pulm Funct Lab, Barcelona, Spain
[5] UT Hlth, San Antonio, TX USA
[6] Regeneron Pharmaceut Inc, Stat, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[7] Sanofi, Global Med Affairs, Bridgewater, MA USA
[8] Regeneron Pharmaceut Inc, Dept Med, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[9] Sanofi, Global Med Affairs Resp Allergy & Gastroenterol, Bridgewater, MA USA
[10] Regeneron Pharmaceut Inc, Immunol & Inflammat, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[11] Sanofi, Global Med, Immunol, Bridgewater, MA USA
[12] Regeneron Pharmaceut Inc, Global Clin Dev, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO01-1
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [41] Long-term dupilumab efficacy across biomarker quadrants in asthma patients: TRAVERSE
    Wechsler, M.
    Pavord, I
    Papi, A.
    Chapman, K.
    Mao, X.
    Ortiz, B.
    Djandji, M.
    Jacob-Nara, J.
    Rowe, P.
    Deniz, Y.
    Laws, E.
    Akinlade, B.
    Amin, N.
    Lederer, D.
    Hardin, M.
    RESPIROLOGY, 2022, 27 : 112 - 113
  • [42] Dupilumab Efficacy in Patients with Moderate-to-Severe Type 2 Asthma With and Without Elevated Blood Neutrophils
    Bleecker, E. R.
    Panettieri, R. A.
    Lugogo, N. L.
    Corren, J.
    Daizadeh, N.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Khodzhayev, A.
    Ortiz, B.
    Ferro, T. J.
    Hansen, C. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [43] LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN CHILDREN WITH ASTHMA: LIBERTY ASTHMA EXCURSION
    Bacharier, L.
    Maspero, J.
    Katelaris, C.
    Fiocchi, A.
    Gagnon, R.
    De Mir-Messa, L.
    Lederer, D.
    Robinson, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S44 - S44
  • [44] ASSESSMENT OF THE LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN CHILDREN WITH ASTHMA (LIBERTY ASTHMA EXCURSION STUDY)
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Connie H.
    Fiocchi, Alessandro
    Gagnon, Remi
    De Mir-Messa, Ines
    Guilbert, Theresa W.
    Jackson, Daniel J.
    Li, Ning
    Akinlade, Bolanle
    Laws, Elizabeth
    Mannent, Leda L. M.
    Maloney, Jennifer
    Tawo, Kelsey
    Khokhar, Faisal A.
    Hardin, Megan
    Abdulai, Raolat
    Lederer, David J.
    Robinson, Lacey B.
    CHEST, 2022, 162 (04) : 2677A - 2679A
  • [45] Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J.
    Wenzel, S.
    Rabe, K. F.
    Busse, W. W.
    Ford, L.
    Sher, L.
    FitzGerald, J. M.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M. H.
    Hamilton, J. D.
    Swanson, B. N.
    Stahl, N.
    Yancopoulos, G. D.
    Teper, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2486 - 2496
  • [46] Long-Term Dupilumab Efficacy on Severe Exacerbations and Lung Function in Patients with Type 2 Asthma
    Papi, Alberto
    Castro, Mario
    Busse, William W.
    Langton, David
    Korn, Stephanie
    Xia, Changming
    Pandit-Abid, Nami
    Radwan, Amr
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (04) : 675 - 679
  • [47] DUPILUMAB REDUCES BIOMARKERS OF TYPE 2 INFLAMMATION IN CHILDREN WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA
    Bacharier, L.
    Maspero, J.
    Katelaris, C.
    Fiocchi, A.
    Liu, D.
    Lederer, D.
    Hardin, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S33 - S33
  • [48] Efficacy of Dupilumab in Pediatric Patients with Uncontrolled, Moderate-to-Severe Asthma With and Without Ongoing Atopic Comorbid Disease: LIBERTY ASTHMA VOYAGE
    Guilbert, T. W.
    Deschildre, A.
    Jackson, D. J.
    Begin, P.
    Zeiger, R. S.
    Szefler, S. J.
    Altincatal, A.
    Gall, R.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    Djandji, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] DUPILUMAB IS WELL TOLERATED AND SHOWS SUSTAINED EFFICACY IN PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE
    Wechsler, M.
    Ford, L.
    Maspero, J.
    Pavord, I.
    Langton, D.
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Amin, N.
    Hardin, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S33 - S33
  • [50] Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction
    Hanania, Nicola A.
    Castro, Mario
    Bateman, Eric
    Pavord, Ian D.
    Papi, Alberto
    FitzGerald, J. Mark
    Maspero, Jorge F.
    Katelaris, Constance H.
    Singh, Dave
    Daizadeh, Nadia
    Altincatal, Arman
    Pandit-Abid, Nami
    Soler, Xavier
    Siddiqui, Shahid
    Laws, Elizabeth
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Lederer, David J.
    Hardin, Megan
    Deniz, Yamo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (02) : 206 - 214.e2
12345